Gerda Andringa

1.5k total citations
32 papers, 1.2k citations indexed

About

Gerda Andringa is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Gerda Andringa has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Neurology, 12 papers in Cellular and Molecular Neuroscience and 6 papers in Molecular Biology. Recurrent topics in Gerda Andringa's work include Parkinson's Disease Mechanisms and Treatments (14 papers), Neuroscience and Neuropharmacology Research (8 papers) and Neurological disorders and treatments (7 papers). Gerda Andringa is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (14 papers), Neuroscience and Neuropharmacology Research (8 papers) and Neurological disorders and treatments (7 papers). Gerda Andringa collaborates with scholars based in Netherlands, United States and Canada. Gerda Andringa's co-authors include Benjamin Drukarch, John G. J. M. Bol, A.R. Cools, M. Catherine Bennett, Thomas N. Chase, J.C. Stoof, F. L. Van Muiswinkel, B. R. K. Douma, P.G.M. Luiten and Kora de Bruin and has published in prestigious journals such as The Journal of Immunology, NeuroImage and The FASEB Journal.

In The Last Decade

Gerda Andringa

31 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerda Andringa Netherlands 18 419 375 330 157 119 32 1.2k
Marcin Piechota Poland 22 445 1.1× 195 0.5× 550 1.7× 185 1.2× 100 0.8× 61 1.4k
Mahesh Kandasamy India 25 482 1.2× 296 0.8× 538 1.6× 148 0.9× 63 0.5× 60 1.6k
P. A. Slominsky Russia 20 377 0.9× 357 1.0× 609 1.8× 195 1.2× 39 0.3× 126 1.4k
Margaret Sutherland United States 15 438 1.0× 192 0.5× 398 1.2× 132 0.8× 82 0.7× 24 994
Yi-Ling Yang Taiwan 18 294 0.7× 257 0.7× 390 1.2× 123 0.8× 51 0.4× 30 1.2k
David S. Zuzga United States 13 745 1.8× 196 0.5× 713 2.2× 307 2.0× 62 0.5× 15 2.0k
Mary B. Newman United States 19 361 0.9× 173 0.5× 591 1.8× 164 1.0× 59 0.5× 29 1.3k
Amanda Moore United States 9 503 1.2× 224 0.6× 520 1.6× 109 0.7× 35 0.3× 17 1.3k
Emiliano Fernández‐Villalba Spain 20 429 1.0× 505 1.3× 320 1.0× 208 1.3× 76 0.6× 48 1.3k
Jarlath M.H. ffrench‐Mullen United States 16 535 1.3× 162 0.4× 597 1.8× 191 1.2× 93 0.8× 18 1.4k

Countries citing papers authored by Gerda Andringa

Since Specialization
Citations

This map shows the geographic impact of Gerda Andringa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerda Andringa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerda Andringa more than expected).

Fields of papers citing papers by Gerda Andringa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerda Andringa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerda Andringa. The network helps show where Gerda Andringa may publish in the future.

Co-authorship network of co-authors of Gerda Andringa

This figure shows the co-authorship network connecting the top 25 collaborators of Gerda Andringa. A scholar is included among the top collaborators of Gerda Andringa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerda Andringa. Gerda Andringa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andringa, Gerda, et al.. (2025). A scoping review of influencing factors associated with loneliness in nursing home settings. Aging & Mental Health. 30(2). 311–324.
2.
Andringa, Gerda, et al.. (2017). The Test Your Memory (TYM) Test Outperforms the MMSE in the Detection of MCI and Dementia. Current Alzheimer Research. 14(6). 598–607. 6 indexed citations
3.
Kortekaas, Rudie, Silvia Eshuis, Gerda Andringa, A. R. Cools, & Klaus L. Leenders. (2013). Motor behavior correlates with striatal [18F]-DOPA uptake in MPTP-lesioned primates. Neurochemistry International. 62(4). 349–353. 5 indexed citations
4.
Wilhelmus, Micha M.M., Gerda Andringa, John G. J. M. Bol, et al.. (2007). 2.429 Tissue transglutaminase is activated and redistributed to ER-derived granules in neuroblastoma cells treated with the PD-mimicking neurotoxin MPP+. Parkinsonism & Related Disorders. 13. S135–S135. 1 indexed citations
5.
Andringa, Gerda, et al.. (2007). The thiol antioxidant 1,2-dithiole-3-thione stimulates the expression of heat shock protein 70 in dopaminergic PC12 cells. Neuroscience Letters. 416(1). 76–81. 6 indexed citations
6.
Andringa, Gerda, et al.. (2006). Changed distribution pattern of the constitutive rather than the inducible HSP70 chaperone in neuromelanin‐containing neurones of the Parkinsonian midbrain. Neuropathology and Applied Neurobiology. 32(2). 157–169. 15 indexed citations
7.
Drukarch, Benjamin, Jeffrey S. Flier, Cornelis A.M. Jongenelen, Gerda Andringa, & Anton N. M. Schoffelmeer. (2005). The antioxidant anethole dithiolethione inhibits monoamine oxidase-B but not monoamine oxidase A activity in extracts of cultured astrocytes. Journal of Neural Transmission. 113(5). 593–598. 23 indexed citations
8.
Andringa, Gerda, Benjamin Drukarch, John G. J. M. Bol, et al.. (2005). Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease. NeuroImage. 26(4). 1150–1158. 44 indexed citations
9.
Broeke, Léon T. van den, et al.. (2004). Dendritic Cell-Induced Activation of Adaptive and Innate Antitumor Immunity. The Journal of Immunology. 173(1). 695–695. 4 indexed citations
10.
Muiswinkel, F. L. Van, Rob A. I. de Vos, John G. J. M. Bol, et al.. (2004). Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigra. Neurobiology of Aging. 25(9). 1253–1262. 128 indexed citations
11.
Broeke, Léon T. van den, et al.. (2003). Dendritic Cell-Induced Activation of Adaptive and Innate Antitumor Immunity. The Journal of Immunology. 171(11). 5842–5852. 83 indexed citations
12.
Andringa, Gerda, Fu Du, Thomas N. Chase, & M. Catherine Bennett. (2003). Mapping of Rat Brain Using the Synuclein-1 Monoclonal Antibody Reveals Somatodendritic Expression of α-Synuclein in Populations of Neurons Homologous to those Vulnerable to Lewy Body Formation in Human Synucleopathies. Journal of Neuropathology & Experimental Neurology. 62(10). 1060–1075. 23 indexed citations
13.
Andringa, Gerda, Silvia Eshuis, Elias Perentes, et al.. (2003). TCH346 prevents motor symptoms and loss of striatal FDOPA uptake in bilaterally MPTP-treated primates. Neurobiology of Disease. 14(2). 205–217. 28 indexed citations
14.
15.
16.
Andringa, Gerda, J.C. Stoof, & A.R. Cools. (1999). Sub-chronic administration of the dopamine D 1 antagonist SKF 83959 in bilaterally MPTP-treated rhesus monkeys: stable therapeutic effects and wearing-off dyskinesia. Psychopharmacology. 146(3). 328–334. 42 indexed citations
17.
Andringa, Gerda, et al.. (1999). The validity of the pretreated, unilaterally MPTP-treated monkey as a model of Parkinson's disease. Behavioural Pharmacology. 10(2). 163–173. 9 indexed citations
18.
19.
Booij, Jan, Gerda Andringa, R. Jeroen Vermeulen, et al.. (1997). [123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys. Synapse. 27(3). 183–190. 90 indexed citations
20.
Andringa, Gerda, R. Jeroen Vermeulen, Benjamin Drukarch, J.C. Stoof, & A.R. Cools. (1997). Dopamine Receptor Subtypes as Targets for the Pharmacotherapy of Parkinson's Disease. Advances in pharmacology. 42. 792–795. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcin Piechota Breakdown of academic impact, for papers by Mahesh Kandasamy Breakdown of academic impact, for papers by P. A. Slominsky Breakdown of academic impact, for papers by Margaret Sutherland Breakdown of academic impact, for papers by Yi-Ling Yang Breakdown of academic impact, for papers by David S. Zuzga Breakdown of academic impact, for papers by Mary B. Newman Breakdown of academic impact, for papers by Amanda Moore Breakdown of academic impact, for papers by Emiliano Fernández‐Villalba Breakdown of academic impact, for papers by Jarlath M.H. ffrench‐Mullen
Rankless by CCL
2026